Pregnancy-related changes of carnitine and acylcarnitine concentrations of plasma and erythrocytes

J Perinat Med. 1995;23(6):477-85. doi: 10.1515/jpme.1995.23.6.477.


Total-, free-, and acylcarnitine concentrations were determined in whole blood, plasma, and red blood cells of 88 women during pregnancy. Already in the 12th week of gestation the mean whole blood carnitine level was significantly (p < 0.01) lower than those of the controls. From the 12th gestational week up to parturition there was a further significant (p < 0.01) decrease. This reduction of total carnitine in whole bloods was mainly caused by a significant (p < 0.01) decrease of free carnitine levels, since no marked changes of short chain acylcarnitine values were found throughout pregnancy. The contribution of red blood cell L-carnitine to whole blood carnitine increased significantly (p < 0.05) to 61% at delivery versus 39% (controls). In umbilical cord blood free and total carnitine levels were significantly (p < 0.05) higher than the corresponding maternal levels. The contribution of red blood cell L-carnitine to whole blood carnitine was higher in cord blood than in maternal blood. The results of the present study demonstrate that during pregnancy whole blood and plasma carnitine levels decrease to those levels found in patients with carnitine deficiency. Also the percentage of acylcarnitine on total carnitine, found in the present study, is characteristic for a secondary carnitine deficiency. Thus L-carnitine substitution in pregnant women, especially in risk pregnancies, may be advantageous.

MeSH terms

  • Acylation
  • Carnitine / analogs & derivatives
  • Carnitine / blood*
  • Carnitine / therapeutic use
  • Case-Control Studies
  • Delivery, Obstetric*
  • Erythrocytes / metabolism*
  • Evaluation Studies as Topic
  • Female
  • Fetal Blood / metabolism*
  • Gestational Age
  • Humans
  • Labor, Obstetric / blood
  • Plasma / chemistry*
  • Pregnancy / blood*


  • Carnitine